Ana Paula Streling de Oliveira

Dr. Ana Paula Streling de Oliveira


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
Ana Carolina Mello SantosAna Carolina Mello Santos
Ana Carolina Mello Santos
RSRosa M. Silva
Rosa M. Silva
TVTiago B. Valiatti
Tiago B. Valiatti
FSFernanda Fernandes dos Santos
Fernanda Fernandes dos Santos
JNJosé Neto
José Neto
TGTania Tardelli Gomes
Tania Tardelli Gomes
Escherichia coli EC121 is a multidrug-resistant (MDR) strain isolated from a bloodstream infection of an inpatient with persistent gastroenteritis and T-zone lymphoma that died due to septic shock. Despite causing an extraintestinal infection, previous studies showed that it did not have the usual characteristics of an extraintestinal pathogenic E. coli. Instead, it belonged to phylogenetic group B1 and harbored few known virulence genes. To evaluate the pathogenic potential of strain EC121, an extensive genome sequencing and in vitro characterization of various pathogenicity-associated properties were performed. The genomic analysis showed that strain EC121 harbors more than 50 complete virulence genetic clusters. It also displays the capacity to adhere to a variety of epithelial cell lineages and invade T24 bladder cells, as well as the ability to form biofilms on abiotic surfaces, and survive the bactericidal serum complement activity. Additionally, EC121 was shown to be virulent in the Galleria mellonella model. Furthermore, EC121 is an MDR strain harboring 14 antimicrobial resistance genes, including blaCTX-M-2. Completing the scenario, it belongs to serotype O154:H25 and to sequence type 101-B1, which has been epidemiologically linked to extraintestinal infections as well as to antimicrobial resistance spread. This study with E. coli strain EC121 shows that clinical isolates considered opportunistic might be true pathogens that go underestimated.

1 October 2018 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
AOAna Paula Streling de Oliveira
Ana Paula Streling de Oliveira
PBPaula P. Barbosa
Paula P. Barbosa
MMMarcelo F.M. Marcondes
Marcelo F.M. Marcondes
ANAdriana G. Nicoletti
Adriana G. Nicoletti
RPRenata C. Picão
Renata C. Picão
AGAna Cristina Gales
Ana Cristina Gales

16 August 2022 in Microbial Drug Resistance
Verified
Journal Article
Closed access
AOAna Paula Streling de Oliveira
Ana Paula Streling de Oliveira
RCRodrigo Cayô
Rodrigo Cayô
CNCarolina S. Nodari
Carolina S. Nodari
LALuiz G.P. Almeida
Luiz G.P. Almeida
FBFelipe Bronze
Felipe Bronze
AGAna Cristina Gales
Ana Cristina Gales
Pseudomonas aeruginosa is an opportunist pathogen usually associated with life threatening infections and exhibits a set of intrinsic and acquired antimicrobial mechanisms. Although resistance to penicillins-like compounds is commonly associated with the chromosomal Pseudomonas -derived cephalosporinases β-lactamase, the real contribution of OXA-50, a second chromosomally encoded β-lactamase, remains unclear. In this study, we characterized the biochemical properties of OXA-50, OXA-488, and OXA-494. Both oxacilinases differ from OXA-50 in two amino acids each. The bla OXA-50 , bla OXA-488 , and bla OXA-494 were cloned into pET26b + that was transformed into Escherichia coli DH5α strain, expressed in E. coli BL21 strain, and then purified for obtaining the hydrolytic parameters. Benzylpenicillin was the preferential substrate instead of oxacillin. Besides, OXA-488 showed a threefold increase in catalytic efficiency for benzylpenicillin, and it was twofold more efficient in hydrolyzing imipenem, compared with OXA-50, although such carbapenemase activity was considered weak. In addition, OXA-488 and OXA-494 showed an increased affinity for penicillins, which contributed to the increased catalytic efficiency against ampicillin, especially OXA-488. Chromosomally encoded resistance mechanisms are usually overshadowed by acquired mechanisms. However, understanding their real contribution is essential to comprehend the versatile profiles verified in P. aeruginosa isolates. Such information can help to choose the best therapy in a scenario of limited options.

1 December 2015 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Closed access
FCFloristher Elaine Carrara-Marroni
Floristher Elaine Carrara-Marroni
RCRodrigo Cayô
Rodrigo Cayô
AOAna Paula Streling de Oliveira
Ana Paula Streling de Oliveira
ASAna Carolina Ramos da Silva
Ana Carolina Ramos da Silva
RPRaquel Lima Palermo
Raquel Lima Palermo
AGAna Cristina Gales
Ana Cristina Gales

1 August 2015 in Journal of Medical Microbiology
Verified
Journal Article
Open access
CCCecilia G. Carvalhaes
Cecilia G. Carvalhaes
ASAna Carolina Ramos da Silva
Ana Carolina Ramos da Silva
AOAna Paula Streling de Oliveira
Ana Paula Streling de Oliveira
RCRodrigo Cayô
Rodrigo Cayô
ARAnna Carolina Rockstroh
Anna Carolina Rockstroh
AGAna Cristina Gales
Ana Cristina Gales

11 April 2024 in Chemosphere
Verified
Journal Article
Closed access
FSFernanda Fernandes dos Santos
Fernanda Fernandes dos Santos
TVTiago Barcelos Valiatti
Tiago Barcelos Valiatti
ASAndré Valencio Siqueira
André Valencio Siqueira
ÁRÁghata Cardoso da Silva Ribeiro
Ághata Cardoso da Silva Ribeiro
AOAna Paula Streling de Oliveira
Ana Paula Streling de Oliveira
AGAna Cristina Gales
Ana Cristina Gales